超声压力估测用于诊断接受透析的慢性肾病患者门静脉高压
本研究为IRB批准试验的亚组研究,纳入20例透析患者,用Sonazoid行SHAPE检查门静脉和肝静脉,并与HVPG及Ludwig-Batts纤维化评分比较。SHAPE与HVPG中度相关(r=0.45),SHAPE可区分轻度和中重度纤维化,HVPG不能,SHAPE诊断准确率80%,HVPG为76%。
要点
- SHAPE与HVPG中度相关(r=0.45;P=.047),提示其可能作为无创替代指标。
- SHAPE可区分轻度(0-1期)与中重度(2-4期)纤维化(-10.4±4.9 dB vs -5.4±3.2 dB;P=.035),HVPG不能(P=.30)。
- SHAPE诊断准确率80%,HVPG为76%,但样本量小。
核心结论
- 在透析患者中,SHAPE似乎比HVPG更准确地预测肝纤维化分期,但样本量小。
研究设计与样本
- IRB批准试验的亚组研究,纳入20例透析患者,使用改良Logiq 9扫描仪(GE,Waukesha,WI)在Sonazoid(GE Healthcare,Oslo,Norway)输注期间行门静脉和肝静脉SHAPE检查,以HVPG和Ludwig-Batts纤维化评分为参考标准。
关键影像表现/征象
- SHAPE在轻度(0-1期)与中重度(2-4期)纤维化间测值分别为-10.4±4.9 dB和-5.4±3.2 dB(P=.035);HVPG分别为3.0±0.6 mmHg和4.8±0.7 mmHg(P=.30)。
诊断标准与关键数值
- SHAPE与HVPG中度相关(r=0.45;P=.047);SHAPE与纤维化呈趋势相关(r=0.42;P=.068),HVPG无相关(r=0.18;P=.45);SHAPE诊断准确率80%,HVPG为76%。
临床应用与阅片要点
- 在透析患者中评估门静脉高压时,SHAPE可能有助于无创判断肝纤维化分期,但样本量小。
局限性
- 样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Hepatic venous pressure gradient (HVPG) is considered the standard in quantifying portal hypertension, but can be unreliable in dialysis patients. A noninvasive ultrasound technique, subharmonic-aided pressure estimation (SHAPE), may be a valuable surrogate of these pressure estimates. This study compared SHAPE and HVPG with pathology findings for fibrosis in dialysis patients.
METHODS: This was a subgroup study from an IRB-approved trial that included 20 patients on dialysis undergoing SHAPE examinations of portal and hepatic veins using a modified Logiq 9 scanner (GE, Waukesha, WI), during infusion of Sonazoid (GE Healthcare, Oslo, Norway). SHAPE was compared to HVPG and pathology findings using the Ludwig-Batts scoring system for fibrosis. Logistic regression, ROC analysis, and t-tests were used to compare HVPG and SHAPE with pathological findings of fibrosis.
RESULTS: Of 20 cases, 5 had HVPG values corresponding to subclinical and clinical portal hypertension (≥6 and ≥10 mmHg, respectively) while 15 had normal HVPG values (≤5 mmHg). SHAPE and HVPG correlated moderately (r = 0.45; P = .047). SHAPE showed a trend toward correlating with fibrosis (r = 0.42; P = .068), while HVPG did not (r = 0.18; P = .45). SHAPE could differentiate between mild (stage 0-1) and moderate to severe (stage 2-4) fibrosis (-10.4 ± 4.9 dB versus -5.4 ± 3.2 dB; P = .035), HVPG could not (3.0 ± 0.6 mmHg versus 4.8 ± 0.7 mmHg; P = .30). ROC curves showed a diagnostic accuracy for SHAPE of 80%, while HVPG reached 76%.
CONCLUSION: Liver fibrosis staging in dialysis patients evaluated for portal hypertension appears to be more accurately predicted by SHAPE than by HVPG; albeit in a small sample size.
引用
- Machado, Gupta, Fenkel, et al. Ultrasound Pressure Estimation for Diagnosing Portal Hypertension in Patients Undergoing Dialysis for Chronic Kidney Disease. J Ultrasound Med. 2021. PMID: 34850412. doi:10.1002/jum.15897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。